A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
Clinical trial NCT00282308 · COMPLETED
Trial details
- NCT number
- NCT00282308
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-23
- Primary completion
- 2008-01-31
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.